[1]
R. R. Mokkarala and J. P. Badugu, “Evaluation of dexmedetomidine as adjuvant to 0.5% ropivacaine in comparison to dexamethasone in supraclavicular block”, Int J Clin Trials, vol. 9, no. 2, pp. 89–93, Apr. 2022.